Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × von Hippel-Lindau Disease × gallium Ga 68 dotatate × Clear all

Phase

Phase 2 2 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1 Endocrine 1 CNS 1

Conditions

Neuroendocrine Tumors 6 Neuroblastoma 2 von Hippel-Lindau Disease 1 Pheochromocytoma 1 Paraganglioma 1 Oncogenic osteomalacia 1 Multiple Endocrine Neoplasia Type 1 1 Meningioma 1 Ganglioneuroma 1 Ganglioneuroblastoma 1 Carcinoid Tumor 1

Interventions

gallium Ga 68 dotatate 1 Magnetic Resonance Spectroscopy 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03001349 2021-02-15

68Ga-DOTA-TOC PET/CT in Imaging Participants With Neuroendocrine Tumors

M.D. Anderson Cancer Center

Phase EARLY_PHASE1 Terminated

CNSEndocrineNET

von Hippel-Lindau Disease, Meningioma, Neuroendocrine Tumors, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon ⚡